![一种小鼠原代肝细胞灌注式分离及离体培养方法](/CN/2019/1/0/images/201910001198.jpg)
基本信息:
- 专利标题: 一种小鼠原代肝细胞灌注式分离及离体培养方法
- 专利标题(英):Mouse primary hepatocyte perfusion type separating and in-vitro culturing method
- 申请号:CN201910001198.8 申请日:2019-01-02
- 公开(公告)号:CN109628377A 公开(公告)日:2019-04-16
- 发明人: 王姿 , 潘聪 , 张汉群
- 申请人: 贵州省人民医院
- 申请人地址: 贵州省贵阳市南明区中山东路83号
- 专利权人: 贵州省人民医院
- 当前专利权人: 贵州省人民医院
- 当前专利权人地址: 贵州省贵阳市南明区中山东路83号
- 代理机构: 北京栈桥知识产权代理事务所
- 代理人: 潘卫锋
- 主分类号: C12N5/071
- IPC分类号: C12N5/071
The invention discloses a mouse primary hepatocyte perfusion type separating and in-vitro culturing method. The perfusion type separating of mouse primary hepatocytes is conduced through an in-situ living body perfusion method, a high-yield single-cell suspension can be obtained, and therefore a basis is provided for in-vitro long-time culturing of the primary hepatocytes. An applied stimulating culture solution contains mouse colony stimulating factors (CSF), mouse IL-2, mouse IL-6 and mouse recombinant hepatocyte growth factors r-mHGF and other cell factors; the primary hepatocytes can be separated through stimulation according to the reasonable ratio for in-vitro proliferation, and the number can reach 2.25 times the number of initially-added primary hepatocytes 72 hours later. The cellproliferation activity can be kept for at least 1-2 weeks under the in-vitro conditions, the problem that the primary hepatocytes cannot be cultured for a long time in vitro is solved, and thereforethe method can be used for infection of retroviruses, provides a basis for over-expression target genes or knockout target genes in in-vitro primary cells, and greatly expands the application field ofthe primary hepatocytes.